Digital Health Startups

MYDUTY is a mobile app for managing nurses' work schedules. It is used by nurses worldwide to organize their shifts.

1 investor

GEM SLEEP provides at-home sleep apnea testing, diagnosis, and treatment, offering patients equipment, supplies, and concierge support without the delays of traditional clinic-based sleep care. The service accepts major insurance plans, is HSA/FSA eligible, and offers cash payment options.

1 investor

myHappymind provides science- and research-based mental wellbeing programmes for primary schools, early years settings and families, giving children tools to build resilience, confidence and lifelong healthy habits. Its curriculum is commissioned by the NHS in some UK schools and validated by a University of Chester study.

1 investor

Hayat provides AI and data science-driven health-tech analytics and digital solutions for global health challenges. The company serves healthcare organizations and clients seeking tailored analytics, data analysis, and customized strategies for health and well-being challenges.

1 investor

MYHIXEL develops medical devices and technology-based solutions for male sexual health, including products for ejaculatory control, erectile function, and pelvic floor strengthening. The company combines clinical evidence with digital platforms and physical devices designed for home use.

1 investor

MyImmune develops AI that analyzes adaptive immune repertoire data to identify drug targets, predict patient responses to immunotherapies, and build biomarkers and companion diagnostics. It serves biotech, pharma, and CRO customers working in oncology, autoimmune, and infectious diseases.

1 investor

MediSage builds digital health technology connecting doctors, patients and healthcare organizations, offering AI-powered clinical decision support, voice-enabled documentation, evidence-based medical education, and patient care tools for nutrition and monitoring. It serves healthcare professionals, patients, and healthcare companies across Asia.

1 investor

MyMeds provides real-time data analytics and member engagement platforms for health plans to improve medication adherence, close care gaps, and optimize Star ratings performance. The platform serves Medicare Advantage plans and other value-based care organizations managing populations with chronic conditions.

1 investor

My Mobile MD provides mobile physician services with onsite providers to deliver primary and urgent care directly to patients, emphasizing personalized treatment plans and direct provider relationships outside traditional healthcare settings.

1 investor

Telemynd is a mental healthcare platform that connects patients with licensed providers through a human-centered approach, prioritizing privacy and continuity of care while using technology to reduce administrative burden and improve access.

1 investor

Mynurva delivers mental health support services for employees, organizations, universities, and charities, combining clinical expertise with digital platforms to make therapy accessible across the UK and MENA region.

1 investor

Myolex develops a portable, non-invasive muscle assessment device based on electrical impedance myography (EIM) that measures single-muscle composition and structure to aid diagnosis, prognosis, and treatment monitoring of neuromuscular and musculoskeletal diseases such as ALS. It serves clinicians, researchers, and pharmaceutical companies, with applications in clinical trials and at-home patient monitoring.

1 investor

Myontec develops wearable technology (MShorts Plus and MSleeves) that monitors muscle activation and load in real time across quadriceps, hamstrings, glutes, and adductors for team sports athletes and coaches focused on performance optimization and injury prevention.

1 investor

Myopia AI is developing an AI-based solution using proprietary models and biologically-based algorithms to stop the progression of myopia (nearsightedness) in children and adults. The company operates in vision health technology, addressing the growing prevalence of myopia and its associated eye-disease risks.

1 investor

Myota makes prebiotic fibre supplements that blend multiple clinically tested fibre sources into a daily scoop to support gut microbiome health, blood sugar control, cholesterol, digestion, and cognitive function. Sold direct to consumers, the products include a general blend and a "Sensitive" low-FODMAP formulation for people with digestive issues.

1 investor

MyPattern is a women's health intelligence platform that integrates lab results, symptoms, wearable data, supplement protocols, and medical history to surface long-term health trends and personalized recommendations. It is designed for women who want to understand their bodies and work alongside their care providers rather than replace them.

1 investor

Myriad Genetics is a genetic testing and precision medicine company that delivers molecular diagnostic test results across hereditary cancer risk, reproductive health, oncology, urology, and mental health. It serves patients and healthcare providers with insights to help detect, treat, and prevent disease.

1 investor

MySecondEar is Germany's leading digital hearing aid provider, offering hearing devices, accessories, and professional fitting services both online and at physical locations. The company serves customers seeking accessible, transparent hearing solutions through a combination of digital and in-person support.

1 investor

MyTrials provides a platform helping patients and families navigate and find clinical trials through AI-driven technology. The service addresses the complexity of trial discovery for individuals seeking medical research participation opportunities.

1 investor

MyUTI is a platform providing UTI testing and support services for women with frequent and stubborn urinary tract infections. The company addresses gaps in women's health diagnostics and treatment by offering reliable testing solutions and clinical guidance.

1 investor

My Well Self is an online wellness care navigation platform that bridges conventional and complementary medicine to improve health outcomes and reduce preventable chronic conditions for individuals, employers, and governments.

1 investor

Myya provides insurance-covered post-mastectomy essentials such as mastectomy bras and breast forms, offering coverage verification, direct insurance billing, and fittings with certified mastectomy fitters online or at select boutique locations. It serves breast cancer survivors and mastectomy patients through a self-guided fit experience and clinical care.

1 investor

Based on the page listing "Ophthalmic Pharmaceutical Consultant" and "Chief Clinical Officer" roles, Nacuity appears to be a pharmaceutical company focused on ophthalmology (eye care), though the page provides insufficient detail to confirm products, customer base, or market focus.

1 investor

Nagish builds Rylo, an accessibility tool that provides communication support across the hearing spectrum for people who are deaf, hard of hearing, aging, or losing their hearing. The company works with the Deaf and hard of hearing community, audiologists, advocacy groups, and nonprofits, and conducts ongoing sign language research.

1 investor